About Ernest Scheidemann
Form D filings for Aspire BioPharma in 2023 list Ernest Scheidemann as executive officer and director.
Ernest Scheidemann first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ernest Scheidemann in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ernest Scheidemann works with at each company, as listed on that company's latest Form D.
Aspire BioPharma, Inc. · Form D, Nov 1, 2023
RP
Rodrick Prat
Director
KH
Kraig Higginson
President and CEO, director
SQ
Stephen Quesenberry
Executive officer and director
EK
Edward Kimball
Director